These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Enhancing Cellular Uptake and Doxorubicin Delivery of Mesoporous Silica Nanoparticles via Surface Functionalization: Effects of Serum. Shahabi S; Döscher S; Bollhorst T; Treccani L; Maas M; Dringen R; Rezwan K ACS Appl Mater Interfaces; 2015 Dec; 7(48):26880-91. PubMed ID: 26562468 [TBL] [Abstract][Full Text] [Related]
5. The shape effect of magnetic mesoporous silica nanoparticles on endocytosis, biocompatibility and biodistribution. Shao D; Lu MM; Zhao YW; Zhang F; Tan YF; Zheng X; Pan Y; Xiao XA; Wang Z; Dong WF; Li J; Chen L Acta Biomater; 2017 Feb; 49():531-540. PubMed ID: 27836804 [TBL] [Abstract][Full Text] [Related]
6. Drug encapsulation and release by mesoporous silica nanoparticles: the effect of surface functional groups. Tan SY; Ang CY; Li P; Yap QM; Zhao Y Chemistry; 2014 Sep; 20(36):11276-82. PubMed ID: 25044108 [TBL] [Abstract][Full Text] [Related]
7. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery. Baeza A; Colilla M; Vallet-Regí M Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898 [TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers. Qu Q; Ma X; Zhao Y Nanoscale; 2015 Oct; 7(40):16677-86. PubMed ID: 26400067 [TBL] [Abstract][Full Text] [Related]
9. Active targeting of mesoporous silica drug carriers enhances γ-secretase inhibitor efficacy in an in vivo model for breast cancer. Wittig R; Rosenholm JM; von Haartman E; Hemming J; Genze F; Bergman L; Simmet T; Lindén M; Sahlgren C Nanomedicine (Lond); 2014 May; 9(7):971-87. PubMed ID: 23898823 [TBL] [Abstract][Full Text] [Related]
10. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery. Giret S; Wong Chi Man M; Carcel C Chemistry; 2015 Sep; 21(40):13850-65. PubMed ID: 26250991 [TBL] [Abstract][Full Text] [Related]
11. Mesoporous silica nanoparticles trigger mitophagy in endothelial cells and perturb neuronal network activity in a size- and time-dependent manner. Orlando A; Cazzaniga E; Tringali M; Gullo F; Becchetti A; Minniti S; Taraballi F; Tasciotti E; Re F Int J Nanomedicine; 2017; 12():3547-3559. PubMed ID: 28507435 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of novel platinum(ii) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application. Pasha SS; Fageria L; Climent C; Rath NP; Alemany P; Chowdhury R; Roy A; Laskar IR Dalton Trans; 2018 Mar; 47(13):4613-4624. PubMed ID: 29517794 [TBL] [Abstract][Full Text] [Related]
13. Mesoporous silica nanoparticles in biomedical applications. Li Z; Barnes JC; Bosoy A; Stoddart JF; Zink JI Chem Soc Rev; 2012 Apr; 41(7):2590-605. PubMed ID: 22216418 [TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Mesoporous Silica Nanoparticles for Targeted Drug Delivery Applications. Abu-Dief AM; Alsehli M; Al-Enizi A; Nafady A Curr Drug Deliv; 2022; 19(4):436-450. PubMed ID: 34238185 [TBL] [Abstract][Full Text] [Related]
15. Hybrid mesoporous silica nanoparticles with pH-operated and complementary H-bonding caps as an autonomous drug-delivery system. Théron C; Gallud A; Carcel C; Gary-Bobo M; Maynadier M; Garcia M; Lu J; Tamanoi F; Zink JI; Wong Chi Man M Chemistry; 2014 Jul; 20(30):9372-80. PubMed ID: 24986399 [TBL] [Abstract][Full Text] [Related]
16. Anticancer Effect of α-Tocopheryl Succinate Delivered by Mitochondria-Targeted Mesoporous Silica Nanoparticles. Qu Q; Ma X; Zhao Y ACS Appl Mater Interfaces; 2016 Dec; 8(50):34261-34269. PubMed ID: 27998109 [TBL] [Abstract][Full Text] [Related]
18. Polyethylenimine-mediated synthetic insertion of gold nanoparticles into mesoporous silica nanoparticles for drug loading and biocatalysis. Pandey PC; Pandey G; Narayan RJ Biointerphases; 2017 Mar; 12(1):011005. PubMed ID: 28347142 [TBL] [Abstract][Full Text] [Related]
19. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. Ma X; Zhao Y; Ng KW; Zhao Y Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533 [TBL] [Abstract][Full Text] [Related]
20. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering. Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]